Nasdaq:HTCR
HeartCore Enterprises, Inc.
HTCR offers specialized healthcare IT solutions aimed at streamlining patient management and operational efficiency within medical facilities.
Key Metrics
Investment Thesis
Bull Case
If HeartCore can transition to profitability within the next 12-18 months, the current low valuation reflects a deep discount that could offer substantial upside potential. The rapid revenue growth trajectory demonstrates strong product-market fit and an expanding addressable market in digital health transformation. Management's ability to leverage existing customer relationships for recurring revenue streams could stabilize cash flows and reduce reliance on equity dilution.
Bear Case
The company has failed to generate positive net income for three consecutive years while simultaneously increasing its deficit, signaling fundamental business model issues. Current liabilities of $7.4M dwarf shareholders' equity of $3.5M, raising serious concerns about solvency and the ability to meet short-term obligations without further dilution. Persistent negative operating cash flow suggests that top-line growth is not translating into efficient operations or profitable scaling.
About HeartCore Enterprises, Inc.
HeartCore Enterprises, Inc. (HTCR) is a healthcare technology provider focused on delivering advanced medical solutions and digital health services. The company serves hospitals, clinics, and private practices with proprietary software platforms designed to optimize patient care workflows. Key products include integrated electronic health record modules and predictive analytics tools for clinical decision support.
Analysis
Management Discussion
While revenue expanded significantly from $8.8M in 2022 to $30.4M in 2024, the company continued to post net losses, widening to $-5.2M in the latest period as operating expenses tracked closely with sales growth. Cash flow from operations turned negative at $-4.8M, offset partially by strong investing cash flows of $6.3M and significant financing activities including share issuances of $1.4M. The balance sheet remains fragile with current liabilities exceeding $7.4M against total equity of only $3.5M, requiring careful monitoring of burn rate and capital structure.
Industry Overview
The global healthcare IT market is experiencing robust expansion driven by the need for interoperability, telehealth integration, and AI-driven diagnostics. Competitors in this space face intense pressure to innovate quickly while navigating complex regulatory landscapes regarding patient data security. Success in this sector increasingly depends on transitioning from one-time implementation fees to recurring subscription models that ensure predictable revenue streams.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $8.8M | $21.8M | $30.4M |
| Cost of Revenue | $5.5M | $13.8M | $12.6M |
| Gross Profit | $3.4M | $8.1M | $17.8M |
| Operating Expenses | $10.0M | $12.2M | $17.8M |
| Operating Income | $-6.7M | $-4.1M | $64.8K |
| R&D | $641.0K | $1.0M | $729.6K |
| G&A | $6.6M | $9.7M | $8.6M |
| Stock-Based Comp | $1.5M | $1.4M | $368.7K |
| D&A | — | $683.0K | $749.6K |
| Depreciation | $83.3K | $98.6K | $112.1K |
| Amortization | — | — | $637.5K |
| Other OpEx | $2.8M | $1.5M | $8.4M |
| Non-Operating Income | $12.7K | $-891.0K | $-5.4M |
| Interest Expense | $41.8K | $163.0K | — |
| Interest Income | $67.0K | $70.6K | $18.8K |
| Pre-Tax Income | $-6.7M | $-5.0M | $-5.3M |
| Income Tax | $-5.9K | $-133.7K | $-136.8K |
| Continuing Ops | $-6.7M | $-4.9M | $-5.2M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-6.7M | $-4.9M | $-5.2M |
| Minority Interest | $0 | $-686.8K | $-3.7M |
| Net to Common | $-6.7M | $-4.2M | $-1.5M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $8.5M | $5.5M | $9.4M |
| Cash & Equivalents | $7.2M | $1.0M | $2.1M |
| Marketable Securities | — | $642.3K | $4.5M |
| Accounts Receivable | $551.1K | $2.6M | $2.0M |
| Other Current Assets | $806.7K | $1.2M | $850.5K |
| Long-Term Assets | $3.6M | $14.1M | $4.5M |
| PP&E (Net) | $203.6K | $763.7K | $584.9K |
| Intangibles | — | $4.5M | — |
| Goodwill | — | $3.3M | — |
| Operating Leases | $2.6M | $2.5M | $1.9M |
| LT Investments | — | $2.0M | $577.8K |
| Other LT Assets | $754.9K | $1.1M | $1.4M |
| Total Assets | $12.1M | $19.6M | $14.0M |
| Current Liabilities | $3.6M | $6.5M | $7.4M |
| Current Debt | $697.9K | $371.8K | $401.3K |
| Current Leases | $291.9K | $396.5K | $372.0K |
| Deferred Revenue | — | — | $1.9M |
| Taxes Payable | — | — | $277.6K |
| Other Current Liab | $2.7M | $5.7M | $4.5M |
| Long-Term Liabilities | $3.7M | $5.4M | $3.1M |
| Long-Term Debt | $1.1M | $1.8M | $1.2M |
| LT Operating Leases | $2.4M | $2.1M | $1.6M |
| Other LT Liab | $138.5K | $977.1K | $227.5K |
| Total Liabilities | $7.3M | $12.0M | $10.5M |
| Shareholders' Equity | $4.8M | $7.7M | $3.5M |
| Paid-In Capital | $15.0M | $19.6M | $20.7M |
| Retained Earnings | $-10.6M | $-14.8M | $-16.2M |
| AOCI | $364.8K | $331.9K | $343.9K |
| Total L&E | $12.1M | $19.6M | $14.0M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-6.7M | $-4.9M | $-5.2M |
| Non-Cash Adjustments | $2.2M | $-704.5K | $-816.0K |
| Working Capital Changes | $-326.1K | $1.2M | $1.3M |
| Cash from Operations | $-4.8M | $-4.3M | $-4.8M |
| Capital Expenditures | $57.1K | $526.3K | $7.4K |
| Cash from Investing | $-12.2K | $-1.8M | $6.3M |
| Debt Issuances | $258.1K | — | — |
| Debt Repayments | $810.8K | $711.4K | — |
| Share Buybacks | $3.5M | — | — |
| Dividends Paid | — | — | $834.6K |
| Cash from Financing | $8.9M | $136.2K | $-318.6K |
| FX Effect | $-54.1K | $-188.9K | $-147.0K |
| Net Change in Cash | $4.0M | $-6.2M | $1.1M |
| Beginning Cash | $3.1M | $7.2M | $1.0M |
| Ending Cash | $7.2M | $1.0M | $2.1M |
Frequently Asked Questions
How does HeartCore Enterprises, Inc. make money?
The company derives revenue primarily from software licensing agreements, maintenance contracts for its proprietary platforms, and custom implementation services for large hospital networks. Additional streams include data analytics subscriptions that help providers predict patient outcomes and reduce readmission rates. A smaller segment involves strategic partnerships with third-party payers to integrate HTCR's technology into their provider networks.
What are the main risks for HTCR?
Persistent net losses and a growing retained earnings deficit indicate the business has yet to achieve sustainable profitability despite recent revenue growth. High levels of current liabilities relative to assets suggest potential liquidity pressures if cash conversion cycles deteriorate or financing conditions tighten. The heavy reliance on common share issuances to fund operations dilutes existing shareholders and may limit future capital raising options. Regulatory changes in healthcare data privacy or reimbursement policies could materially impact the valuation of their software contracts.
What is HTCR's competitive advantage?
HTCR possesses deep domain expertise in niche clinical workflows that larger competitors overlook, creating high switching costs for established customers. The company maintains a lightweight asset structure with minimal depreciation burdens, allowing flexibility to pivot quickly as regulatory environments change. Proprietary algorithms trained on longitudinal patient data provide insights that are difficult for new entrants to replicate without significant time investment.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.